The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation

scientific article

The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/MCB.24.17.7514-7523.2004
P8608Fatcat IDrelease_gcucv53ehrdvdaunt4n7orrywu
P932PMC publication ID506993
P698PubMed publication ID15314161
P5875ResearchGate publication ID8397600

P2093author name stringAna Aranda
Susana García-Silva
P2860cites workRequirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3Q22010472
The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domainQ24600925
An element in the region responsible for premature termination of transcription mediates repression of c-myc gene expression by thyroid hormone in neuroblastoma cellsQ28142137
Thyroid hormone receptors/THR genes in human cancerQ28187712
Physiological and molecular basis of thyroid hormone actionQ28203934
Nuclear hormone receptors and gene expressionQ28203943
Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinaseQ28283499
The signal-dependent coactivator CBP is a nuclear target for pp90RSKQ28286828
Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinasesQ28298000
Ras signalling linked to the cell-cycle machinery by the retinoblastoma proteinQ28305440
ras oncogenes in human cancer: a reviewQ29547769
Regulation of transcription by MAP kinase cascadesQ29618477
CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signalsQ29620470
Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancerQ33682080
The v-erbA oncogene (review).Q33736584
Fos family members induce cell cycle entry by activating cyclin D1.Q33779543
pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-Q33854336
Specific protection against breast cancers by cyclin D1 ablationQ34082446
Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormonesQ34083450
Ras proteins in the control of the cell cycle and cell differentiationQ34090530
AP-1--glucocorticoid receptor crosstalk taken to a higher levelQ34262748
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regionsQ34295503
Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation.Q34479232
Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinomaQ34579987
The thyroid hormone receptor antagonizes CREB-mediated transcriptionQ35107692
Overexpression of the beta 1 thyroid receptor induces differentiation in neuro-2a cellsQ35127027
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivoQ35207717
Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cellsQ36552538
The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear exportQ39455172
Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB.Q39456448
8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding proteinQ39456804
Negative regulation of expression of the pituitary-specific transcription factor GHF-1/Pit-1 by thyroid hormones through interference with promoter enhancer elementsQ40017619
The mechanism of cell cycle regulation by v-Src.Q40775817
Nuclear receptor/AP-1 interactionQ40791352
Function and regulation of ras.Q40835314
Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR.Q40855677
The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiationQ40973624
Induction of cyclin D1 overexpression by activated ras.Q41415663
Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenesQ41654734
Inducible regulatory elements in the human cyclin D1 promoterQ42498965
Multiple ras effector pathways contribute to G(1) cell cycle progressionQ42812883
Evidence that Ha-Ras mediates two distinguishable intracellular signals activated by v-SrcQ42816578
Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinomaQ43833469
Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer.Q43945213
Transcriptional cross-talk, the second mode of steroid hormone receptor actionQ47862003
Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.Q52548664
Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene productQ59098062
Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer.Q64979538
Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cellsQ72992472
Transcriptional activation of the cyclin D1 gene is mediated by multiple cis-elements, including SP1 sites and a cAMP-responsive element in vascular endothelial cellsQ73054399
Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27Q73959940
P433issue17
P407language of work or nameEnglishQ1860
P304page(s)7514-7523
P577publication date2004-09-01
P1433published inMolecular and Cellular BiologyQ3319478
P1476titleThe thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation
P478volume24

Reverse relations

cites work (P2860)
Q40147190A hybrid CMV-H1 construct improves efficiency of PEI-delivered shRNA in the mouse brain.
Q54189015Association between promoter methylation and expression of thyroid hormone receptor beta (THRβ) gene in patients with gastric cancer in an Iranian population.
Q39415249Cell-type-dependent thyroid hormone effects on glioma tumor cell lines.
Q92502907Deiodinases and their intricate role in thyroid hormone homeostasis
Q34692085Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study.
Q34914923Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis
Q33775577Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma
Q37831909Hedgehog-mediated regulation of thyroid hormone action through iodothyronine deiodinases
Q33488530Hypothyroidism enhances tumor invasiveness and metastasis development
Q28582121Involvement of cAMP-response element binding protein-1 in arachidonic acid-induced vascular smooth muscle cell motility
Q37643737Iodine mediated mechanisms and thyroid carcinoma
Q46985015Iodothyronine deiodinases expression in thyroid neoplasias
Q33819911Lessons from mouse models of thyroid cancer
Q38766990Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
Q35832908Modeling follicular thyroid cancer for future therapies
Q35135691Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas
Q36208333Mutation analysis underlying the downregulation of the thyroid hormone receptor β1 gene in the Chinese breast cancer population
Q58086853Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer
Q35931083Nuclear receptor, coregulator signaling, and chromatin remodeling pathways suggest involvement of the epigenome in the steroid hormone response of endometrium and abnormalities in endometriosis
Q35781521Oncogenic mutations of thyroid hormone receptor β.
Q37599892Role of type 3 deiodinase in cancer
Q34654368Src-dependent phosphorylation at Y406 on the thyroid hormone receptor β confers the tumor suppressor activity
Q26746255T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair
Q58589490The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism
Q37441332The thyroid hormone receptor β induces DNA damage and premature senescence.
Q35085091The thyroid hormone receptors as modulators of skin proliferation and inflammation
Q88639338Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling
Q38766996Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer
Q64260591Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies
Q33631853Thyroid hormone increases bulk histones expression by enhancing translational efficiency
Q40194625Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic
Q37455473Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire
Q35099103Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis
Q36206509Thyroid hormone receptor β suppresses SV40-mediated tumorigenesis via novel nongenomic actions
Q64460314Thyroid hormone receptor β1 domains responsible for the antagonism with the ras oncogene: role of corepressors
Q42820152Thyroid hormone receptor-beta (TR beta 1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2.
Q36238475Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma
Q28752413Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs
Q36158417Transcriptomal profiling of site-specific Ras signals
Q34356150Unexpected maturation of PI3K and MAPK-ERK signaling in fetal ovine cardiomyocytes